Stock Events

Stock Events

ImpediMed 

A$0.02
5
+A$0+0% Wednesday 23:20

Statistics

Day High
0.02
Day Low
0.02
52W High
0.06
52W Low
0.02
Volume
537,337
Avg. Volume
6,261,221
Mkt Cap
30.57M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

25FebExpected
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-0.01
-0
-0
0
Expected EPS
-0.001874455712560047
Actual EPS
-0.0056233671376801405

Financials

-182.62%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
25.45MRevenue
-46.47MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IPD.AU. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories offers products and systems used to separate complex chemical and biological materials, similar to ImpediMed's bioimpedance spectroscopy solutions for fluid status monitoring.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation operates in the medical, industrial, and commercial sectors, offering products that compete in the diagnostics and research market alongside ImpediMed.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, overlapping with ImpediMed's market.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a broad range of medical devices, diagnostics, and nutritional products that compete with ImpediMed's solutions in the healthcare sector.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc specializes in medical technologies, services, and solutions, including diagnostic and monitoring devices that compete with ImpediMed's offerings.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing with ImpediMed in the medical device sector.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation is involved in the development, manufacture, and sale of medical devices, including surgical and patient monitoring products that compete with ImpediMed.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. focuses on diagnostics, medical imaging systems, and surgical products, particularly in women's health, where it competes with ImpediMed's diagnostic solutions.
GE Aerospace
GE
Mkt Cap325.88B
General Electric Company, through its healthcare division, provides medical imaging, monitoring, biomanufacturing, and cell therapy technology, competing with ImpediMed in the medical diagnostics and monitoring space.
Koninklijke Philips N.V.
PHG
Mkt Cap26.17B
Koninklijke Philips N.V. offers health technology products and services in diagnostics, treatment, and connected care, with solutions that compete with ImpediMed's bioimpedance technology.

About

ImpediMed Limited, a medical technology company, develops, manufactures and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema, which uses bioimpedance measurements to assess fluid levels and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-care body composition analysis; and HF-Dex analysis for point-of-care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. ImpediMed Limited was incorporated in 1999 and is headquartered in Carlsbad, California with additional office in Lindfield, Australia.
Show more...
CEO
Dr. Parmjot Bains M.D.
Employees
77
Country
AU
ISIN
AU000000IPD8

Listings

F
DE
R1J.F
AU
AU
IPD.AU
OTC Link
US
IPDQF

0 Comments

Share your thoughts

FAQ

What is ImpediMed stock price today?▼
The current price of IPD.AU is A$0.02 AUD — it has increased by +0% in the past 24 hours. Watch ImpediMed stock price performance more closely on the chart.
What is ImpediMed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ImpediMed stocks are traded under the ticker IPD.AU.
Is ImpediMed stock price growing?▼
IPD.AU stock has risen by +0% compared to the previous week, the month change is a -11.76% fall, over the last year ImpediMed has showed a -61.54% decrease.
What is ImpediMed market cap?▼
Today ImpediMed has the market capitalization of 30.57M
When is the next ImpediMed earnings date?▼
ImpediMed is going to release the next earnings report on August 27, 2026.
What were ImpediMed earnings last quarter?▼
IPD.AU earnings for the last quarter are -0.01 AUD per share, whereas the estimation was -0 AUD resulting in a -200% surprise. The estimated earnings for the next quarter are N/A AUD per share.
What is ImpediMed revenue for the last year?▼
ImpediMed revenue for the last year amounts to 25.45M AUD.
What is ImpediMed net income for the last year?▼
IPD.AU net income for the last year is -46.47M AUD.
How many employees does ImpediMed have?▼
As of April 05, 2026, the company has 77 employees.
In which sector is ImpediMed located?▼
ImpediMed operates in the Health Care sector.
When did ImpediMed complete a stock split?▼
ImpediMed has not had any recent stock splits.
Where is ImpediMed headquartered?▼
ImpediMed is headquartered in Carlsbad, AU.